Status:
COMPLETED
A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss
Lead Sponsor:
Merz Pharmaceuticals GmbH
Collaborating Sponsors:
LLC Merz Pharma, Russia
Conditions:
Female Pattern Hair Loss
Androgenetic Alopecia (AGA)
Eligibility:
FEMALE
18-45 years
Phase:
PHASE2
Brief Summary
Pantovigar - a high effective product designed primarily for the treatment of diffuse hair loss in women as well as for the treatment of damaged hair, in the combined therapy can be successfully appli...
Eligibility Criteria
Inclusion
- Female patient complaint of hair loss and/or hair density reduction for more than 3 months.
- More than 15 % of telogen frontoparietal hair as shown in the phototrichogram.
Exclusion
- Symptomatic diffuse alopecia (screening for iron and thyroid function, thyroid stimulating hormon, triiodothyrine, ferritin , total iron-binding capacity)
- Active or history of systemic autoimmune disease, e.g. lupus erythematodes etc.
- Hyperandrogenic alopecia (polycystic ovary syndrome, adrenogenital syndrome, tumors with androgenic activity) (testosterone, prolactin hormone, androstenedione, dehydroepiandrosterone)
- Initiation or termination of hormone therapy within 6 months prior to entering study
- Hormone therapy with androgenic action, e.g. norethisterone etc.
- Pregnancy or lactation within 6 months prior to entering study
- Alopecia areata
- Scarring alopecia
- Treatment with hair promoting agent within 3 months prior to entering study
- Known hair loss after drug intake
- Concomitant use of the drugs causing a hair loss (e.g. aromatase inhibitors, thyreostatics, cytostatics, etc,)
Key Trial Info
Start Date :
April 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT01900041
Start Date
April 1 2012
End Date
July 1 2013
Last Update
December 12 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
State Scientific Center of Dermatology and Cosmetology
Moscow, Russia, 107076
2
Moscow Scientific Clinical Center of Dermatology and Cosmetology
Moscow, Russia, 119071